Overall, our pan-cancer systems-level analysis reveals that RKIP and BACH1 can control multiple axes of plasticity (EMT, metabolic reprogramming, stemness) together in opposite directions, thus explaining their association with patient survival seen across cancer types. The gene discussed is BACH1; the disease is cancer.